FOSALEN D3
DCI : ALENDRONATE+COLECALCIFEROL
Dosage 70 mg/ 5600 UI
Pharmaceutical form Scored tablet
Therapeutic class Rhumatology
B/4
Indications
Treatment of post-menopausal osteoporosis for patients at risk for vitamin D deficiency and not receiving additional vitamin D intake. FOSALEN D3 reduces the risk of vertebral and hip fractures.
Download the leaflet
